文献速递哮喘

1990-2019年204个国家哮喘患病率、死亡及伤残调整寿命年负担与归因风险因素

Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019.
PubMed 文献 · Chest · 2021-10-23

基于全球疾病负担研究1990-2019年数据,分析204个国家哮喘的年龄标化患病率、死亡率及伤残调整寿命年(DALY)。2019年全球年龄标化患病率为3415.5/10万、死亡率为5.8/10万,较1990年分别下降24%和51.3%;DALY率为273.6/10万,5-9岁组患病率最高,高BMI、吸烟和职业性哮喘诱因分别贡献16.9%、9.9%和8.8%的DALY。

要点

  • 2019年全球哮喘年龄标化患病率3415.5/10万,死亡率5.8/10万,较1990年分别下降24%和51.3%。
  • 5-9岁年龄组哮喘点患病率最高,美国年龄标化患病率最高(10399.3/10万)。
  • 高BMI、吸烟和职业性哮喘诱因分别贡献2019年哮喘DALY的16.9%、9.9%和8.8%。

核心结论

  • 哮喘仍是重要公共卫生问题,尤其在社会经济发展水平较低地区负担更重。
  • 需进一步研究哮喘与风险因素的关联及阻碍最佳自我管理的因素。

研究设计与样本

  • 基于全球疾病负担研究1990-2019年公开数据,覆盖204个国家和地区。
  • 按年龄、性别和社会人口指数(SDI)分析哮喘负担,估计值以计数和每10万年龄标化率及不确定性区间呈现。

主要发现

  • 2019年全球哮喘年龄标化点患病率为3415.5/10万,较1990年下降24%。
  • 2019年全球哮喘年龄标化死亡率为5.8/10万,较1990年下降51.3%。
  • 2019年全球年龄标化DALY率为273.6/10万。
  • 2019年全球哮喘点患病率在5-9岁年龄组最高。
  • 2019年美国年龄标化点患病率最高,为10399.3/10万。

关键数值与推荐

  • 2019年全球哮喘年龄标化点患病率3415.5/10万(较1990年下降24%)。
  • 2019年全球哮喘年龄标化死亡率5.8/10万(较1990年下降51.3%)。
  • 2019年全球年龄标化DALY率273.6/10万。
  • 2019年归因于高BMI、吸烟和职业性哮喘诱因的哮喘DALY分别占16.9%、9.9%和8.8%。

临床怎么用

  • 关注5-9岁儿童哮喘患病负担,早期识别与管理。
  • 重视高BMI、吸烟和职业性哮喘诱因的防控以降低哮喘DALY。
  • 在低SDI地区加强哮喘负担监测与自我管理支持。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding global trends in the point prevalence, deaths, and disability-adjusted life-years (DALYs) for asthma will facilitate evidence-based decision-making. RESEARCH QUESTION: What are the global, regional, and national burdens of asthma in 204 countries and territories between 1990 and 2019 by age, sex, and sociodemographic index (SDI)? STUDY DESIGN AND METHODS: Publicly available data from the Global Burden of Disease study from 1990 through 2019 were used. All estimates were presented as counts and age-standardized rates per 100,000, along with their associated uncertainty intervals. RESULTS: In 2019, the global age-standardized point prevalence and death rates for asthma were 3,415.5 and 5.8 per 100,000, which represent a 24% and 51.3% decrease since 1990, respectively. Moreover, in 2019, the global age-standardized DALY rate was 273.6 and the global point prevalence of asthma was highest in the group 5 to 9 years of age. Also in 2019, the United States (10,399.3) showed the highest age-standardized point prevalence rate of asthma. Generally, the burden of asthma decreased with increasing SDI. Globally, high BMI (16.9%), smoking (9.9%), and occupational asthmagens (8.8%) contributed to the 2019 asthma DALYs. INTERPRETATION: Asthma remains an important public health issue, particularly in regions with low socioeconomic development. Future research is needed to examine thoroughly the associations asthma has with its risk factors and the factors impeding optimal self-management. Further research also is needed to understand and implement better the interventions that have reduced the burden of asthma.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Safiri S, Carson-Chahhoud K, Karamzad N, et al. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019. Chest. 2021. PMID: 34699773. doi:10.1016/j.chest.2021.09.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。